Corticosteroid derivatives - IVAXAlternative Names: Soft steroids - IVAX
Latest Information Update: 07 Aug 2007
At a glance
- Originator IVAX Corporation
- Developer IVAX Drug Research Institute
- Mechanism of Action Steroid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Allergic conjunctivitis; Allergic rhinitis; Emphysema; Inflammation
Most Recent Events
- 27 Jan 2006 IVAX Corporation has been acquired by Teva Pharmaceutical Industries
- 14 Jun 2001 Preclinical development for Emphysema in Hungary (Inhalation)
- 31 Dec 1999 Preclinical development for Inflammation in Hungary (Unknown route)